Syntekabio is a public company, listed on the KOSDAQ. It is an AI drug discovery and development company based on genomic big data.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Daejeon
State: Taejon-jikhalsi
Zip:
Country: South Korea
Syntekabio is a Korean biotech firm, developing personal genome map which is expected to enable personalized medical service. The company also provides a technology for collecting and integrating decrypted whole genome data.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2016 | Series A | 1 | $5.1M |
Altos Ventures Altos Ventures |
5/2018 | Series B | 4 | $11.1M |
Altos Ventures Korea Development Bank Smilegate Investment Yozma Group Korea Altos Ventures Korea Development Bank Smilegate Investment Yozma Group Korea |
1/2019 | Series C | 3 | $17.7M |
Saehan Venture Capital Timewise Investment Yuhan Corporation Saehan Venture Capital Timewise Investment Yuhan Corporation |
12/2019 | Post-IPO Equity | $150M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|